Cord Blood Stem Cell TransplantationTransplantation, AutologousFetal BloodTransplantation, HomologousHematopoietic Stem Cell TransplantationTransplantation ConditioningGraft vs Host DiseaseHematologic NeoplasmsLiver TransplantationHistocompatibility TestingBone Marrow TransplantationGraft SurvivalTransplantation ChimeraKidney TransplantationTissue DonorsBlood Transfusion, AutologousHistocompatibilityTreatment OutcomeBlood BanksStem Cell TransplantationMyeloablative AgonistsTransplantsAllograftsHLA AntigensHeart TransplantationLung TransplantationLeukemiaGraft RejectionImmunogenetic PhenomenaPeripheral Blood Stem Cell TransplantationWhole-Body IrradiationChimerismImmunosuppressive AgentsRetrospective StudiesRecurrenceHematologic DiseasesTime FactorsGraft vs Leukemia EffectOrgan TransplantationUnrelated DonorsCell TransplantationCytomegalovirus InfectionsSurvival AnalysisVidarabineDisease-Free SurvivalVolvariellaAntilymphocyte SerumHematopoietic Stem CellsIslets of Langerhans TransplantationPancreas TransplantationBlood DonorsTransplantation ImmunologySurvival RateAnemia, AplasticTransplantationLeukemia, Myeloid, AcuteCombined Modality TherapyLeukodystrophy, Globoid CellAcute DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaAntigens, CD34Follow-Up StudiesMyelodysplastic SyndromesColony-Forming Units AssayHematopoiesisTransplantation, IsogeneicLeukocyte CountImmunophenotypingMelphalanTransplantation, HeterotopicLiving DonorsInfectionInfant, NewbornMultiple MyelomaCyclophosphamideImmunosuppressionCytomegalovirusT-LymphocytesEpstein-Barr Virus InfectionsRemission InductionHeart-Lung TransplantationNeutrophilsLymphoma, Non-HodgkinAntineoplastic Combined Chemotherapy ProtocolsKiller Cells, NaturalRisk FactorsMesenchymal Stem Cell TransplantationBone Marrow PurgingPostoperative ComplicationsTransplantation ToleranceSkin TransplantationTissue and Organ ProcurementCarmustineCells, CulturedTissue TransplantationBusulfanFetal Tissue TransplantationHematopoietic Stem Cell MobilizationCyclosporineLiver Failure